Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PALM: Abicipar Pegol in Diabetic Macular Edema
NCT02186119Phase 2Completed
- Sponsor
- Allergan
- Start
- Jul 2014
- Primary completion
- Jun 2015
- Modality
- Carrier/Scaffold Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abicipar pegol in diabetic macular edema (DME), sponsored by Allergan. Started Jul 2014; status: completed.
02
Drugs
abicipar pegol
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02186119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02186119.